Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kenna

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Genomics|November 1, 1992
Evidence for nonallelic genetic heterogeneity in autosomal recessive retinitis pigmentosaL M Bleeker-Wagemakers, A Gal, R Kumar-Singh, et al.
European Journal of Human Genetics : EJHG|January 8, 2021
Genetic analysis of ALS cases in the isolated island population of MaltaRebecca Borg, Maia Farrugia Wismayer, Karl Bonavia, et al.
Nature Genetics|February 1, 1997
Retinopathy induced in mice by targeted disruption of the rhodopsin geneM M Humphries, D Rancourt, G J Farrar, et al.
Brain Communications|April 20, 2022
Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosisSarah Boddy, Mahjabin Islam, Tobias Moll, et al.
Cell Systems|June 11, 2022
Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severitySai Zhang, Johnathan Cooper-Knock, Annika K Weimer, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2021
Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severitySai Zhang, Johnathan Cooper-Knock, Annika K Weimer, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
predicTTE: An accessible and optimal tool for time-to-event prediction in neurological diseasesMarcel Weinreich, Harry McDonough, Nancy Yacovzada, et al.
Nature Genetics|June 10, 2024
Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson's diseasePaul J Hop, Dongbing Lai, Pamela J Keagle, et al.
Cell Reports|December 2, 2020
Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk GeneJohnathan Cooper-Knock, Sai Zhang, Kevin P Kenna, et al.
Cell Reports|February 3, 2021
Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk geneJohnathan Cooper-Knock, Sai Zhang, Kevin P Kenna, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Genomics|November 1, 1992
Evidence for nonallelic genetic heterogeneity in autosomal recessive retinitis pigmentosaL M Bleeker-Wagemakers, A Gal, R Kumar-Singh, et al.
European Journal of Human Genetics : EJHG|January 8, 2021
Genetic analysis of ALS cases in the isolated island population of MaltaRebecca Borg, Maia Farrugia Wismayer, Karl Bonavia, et al.
Nature Genetics|February 1, 1997
Retinopathy induced in mice by targeted disruption of the rhodopsin geneM M Humphries, D Rancourt, G J Farrar, et al.
Brain Communications|April 20, 2022
Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosisSarah Boddy, Mahjabin Islam, Tobias Moll, et al.
Cell Systems|June 11, 2022
Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severitySai Zhang, Johnathan Cooper-Knock, Annika K Weimer, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2021
Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severitySai Zhang, Johnathan Cooper-Knock, Annika K Weimer, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
predicTTE: An accessible and optimal tool for time-to-event prediction in neurological diseasesMarcel Weinreich, Harry McDonough, Nancy Yacovzada, et al.
Nature Genetics|June 10, 2024
Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson's diseasePaul J Hop, Dongbing Lai, Pamela J Keagle, et al.
Cell Reports|December 2, 2020
Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk GeneJohnathan Cooper-Knock, Sai Zhang, Kevin P Kenna, et al.
Cell Reports|February 3, 2021
Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk geneJohnathan Cooper-Knock, Sai Zhang, Kevin P Kenna, et al.
Pageof 8